AmeriPath

We're excited to announce a research collaboration with Mass General Brigham investigators at Massachusetts Eye and Ear and Massachusetts General Hospital, world-renowned centers for head and neck and advanced cutaneous oncology. The research collaboration will investigate the use of Haystack MRD, a highly sensitive circulating tumor DNA (ctDNA) minimal residual disease test, as an aid in postoperative therapy decisions for two cancer types: cutaneous squamous cell carcinoma (CSCC), a type of skin cancer, and HPV-independent head and neck squamous cell carcinoma (HNSCC). "In aggressive and often unpredictable cancers like HNSCC and CSCC, the ability to sensitively detect minimal residual disease can transform how we evaluate treatment response and monitor for recurrence. Studying these diseases with Haystack MRD offers a critical opportunity to close the gap between clinical remission and molecular relapse—bringing us closer to truly personalized, proactive cancer care," said Dan Edelstein, Vice President and General Manager of Haystack Oncology. Read the full press release at https://xmrrwallet.com/cmx.phubs.ly/Q03BMV8L0

Please join us in welcoming Zaid Khreefa, MD! Dr. Khreefa is board-certified in Anatomic and Clinical Pathology and specializes in gastrointestinal and liver pathology. Dr Khreefa is located at AmeriPath in Twinsburg, OH. #WelcomeWednesday #newteammember

Please join us in welcoming Akif Koray Guney, MD! Dr. Guney is board-certified in Anatomic and Clinical Pathology and is located at AmeriPath in Shelton, CT. #WelcomeWednesday #newteammember

Please join us in welcoming Albert Sy, MD! Dr. Sy is board-certified in Anatomic and Clinical Pathology and is located at AmeriPath in Indianapolis, IN. #WelcomeWednesday #newteammember #AmeriPath

Join us at booth 300 during the College of American Pathologists (CAP) Meeting in Orlando on September 13-16 to explore the power of partnering with AmeriPath for your pathology testing needs. Engage with our team and discover the ease of integrating cutting-edge technology into your practice. #AmeriPath #QuestDiagnostics #CAP25 #pathologists

AmeriPath continues to partner with companies like PathAI to stay at the forefront of digital pathology. We are excited by the recent announcement that AISight® Dx has received FDA clearance for use as an aid in primary diagnosis with FDA-approved or cleared whole slide image scanners. #digitalpathology #AmeriPath #PathAI

Still wrestling with paper requisitions? Go beyond the test by partnering with #AmeriPath, who provides subspecialty pathology expertise, digital pathology, superlative logistics, and integration with more than 920 LIS/EHRs. Learn more by visiting: www.AmeriPath.com

In cancer care, every minute counts. Is your diagnostic partner keeping up? Go beyond the test by partnering with #AmeriPath, who provides subspecialty pathology expertise, superlative logistics, and integration with more than 920 LIS/EHRs. Learn more by visiting: www.AmeriPath.com

Please join us in welcoming Dana Wolinsky, MD! Dr. Wolinsky is board-certified in anatomic and clinical pathology and fellowship trained in neuropathology. She is located at Phenopath in Seattle, WA. #WelcomeWednesday #newteammember

Please join us in welcoming Ilya Stone, MD! Dr. Stone is board-certified in anatomic and clinical pathology and fellowship trained in surgical pathology and cytopathology. He is located at AmeriPath in Memphis, TN. #WelcomeWednesday #newteammember